APRICUS BIOSCIENCES, INC. Contracts & Agreements

Amendment No. 8 to Convertible Promissory Note, by and between Seelos Therapeutics, Inc. and Lind Global Asset Management V, LLC, effective July 16, 2024 (Filed With SEC on July 16, 2024)

Form of New Warrant (Filed With SEC on July 12, 2024)

Form of Placement Agent Warrant (Filed With SEC on July 12, 2024)

Form of Inducement Letter (Filed With SEC on July 12, 2024)

Amendment No. 7 to Convertible Promissory Note, by and between Seelos Therapeutics, Inc. and Lind Global Asset Management V, LLC, effective June 1, 2024 (Filed With SEC on June 5, 2024)

Form of Pre-Funded Warrant (Filed With SEC on May 21, 2024)

Form of Common Warrant (Filed With SEC on May 21, 2024)

Form of Securities Purchase Agreement, dated May 16, 2024 (Filed With SEC on May 21, 2024)

Placement Agency Agreement, dated May 16, 2024 (Filed With SEC on May 21, 2024)

Amendment No. 6 to Convertible Promissory Note, by and between Seelos Therapeutics, Inc. and Lind Global Asset Management V, LLC, effective May 1, 2024 (Filed With SEC on May 3, 2024)

Amendment No. 5 to Convertible Promissory Note, by and between Seelos Therapeutics, Inc. and Lind Global Asset Management V, LLC, effective March 27, 2024 (Filed With SEC on March 28, 2024)

Description of Securities of Seelos Therapeutics, Inc (Filed With SEC on March 6, 2024)

Form of Common Warrant (Filed With SEC on January 30, 2024)

Form of Securities Purchase Agreement, dated January 26, 2024 (Filed With SEC on January 30, 2024)

Placement Agent Agreement, dated January 26, 2024 (Filed With SEC on January 30, 2024)

Underwriting Agreement, dated as of November 28, 2023, by and between Seelos Therapeutics, Inc. and Titan Partners Group, LLC (Filed With SEC on November 30, 2023)

Form of Pre-Funded Warrant (Filed With SEC on November 30, 2023)

Form of Common Warrant (Filed With SEC on November 30, 2023)

Amendment No. 4 to Convertible Promissory Note and Amendment to Letter Agreement, by and between Seelos Therapeutics, Inc. and Lind Global Asset Management V, LLC, effective... (Filed With SEC on October 2, 2023)

Form of Warrant (Filed With SEC on September 25, 2023)

Form of Securities Purchase Agreement, dated September 21, 2023 (Filed With SEC on September 25, 2023)

Letter Agreement, dated September 21, 2023, by and between Seelos Therapeutics, Inc. and Lind Global Asset Management V, LLC (Filed With SEC on September 25, 2023)

Amendment No. 3 to Convertible Promissory Note, by and between Seelos Therapeutics, Inc. and Lind Global Asset Management V, LLC, dated May 19, 2023 (Filed With SEC on May 19, 2023)

Form of Warrant, dated May 19, 2023 (Filed With SEC on May 19, 2023)

Form of Amendment No. 1 to Securities Purchase Agreement, by and between Seelos Therapeutics, Inc. and each purchaser identified on the signature pages thereto, dated May 19, 2023 (Filed With SEC on May 19, 2023)

Form of Pre-Funded Warrant (Filed With SEC on March 14, 2023)

Form of Common Warrant (Filed With SEC on March 14, 2023)

Form of Securities Purchase Agreement, dated March 10, 2023 (Filed With SEC on March 14, 2023)

Description of Securities of Seelos Therapeutics, Inc (Filed With SEC on March 10, 2023)

Amendment No. 2 to Convertible Promissory Note, by and between Seelos Therapeutics, Inc. and Lind Global Asset Management V, LLC, dated February 8, 2023 (Filed With SEC on March 10, 2023)

Non-Employee Director Compensation Policy (Filed With SEC on March 10, 2023)

Open Market Sale AgreementSM, dated as of May 12, 2022, by and between Seelos Therapeutics, Inc. and Jefferies LLC (Filed With SEC on May 12, 2022)

Amendment No. 5 to Asset Purchase Agreement, dated April 8, 2022, by and between Seelos Corporation and Phoenixus AG (Filed With SEC on April 11, 2022)

Description of Securities of Seelos Therapeutics, Inc (Filed With SEC on March 4, 2022)

Amendment to Convertible Promissory Note, by and between Seelos Therapeutics, Inc. and Lind Global Asset Management V, LLC, dated December 10, 2021 (Filed With SEC on March 4, 2022)

Amended and Restated Employment Agreement by and between Seelos Therapeutics, Inc. and Raj Mehra, Ph.D., dated as of January 10, 2022 (Filed With SEC on January 10, 2022)

Form of Convertible Promissory Note due November 23, 2024 (Filed With SEC on November 24, 2021)

Securities Purchase Agreement, dated as of November 23, 2021, by and between Seelos Therapeutics, Inc. and Lind Global Asset Management V, LLC (Filed With SEC on November 24, 2021)

Security Agreement, dated as of November 23, 2021, by and between Seelos Therapeutics, Inc. and Lind Global Asset Management V, LLC (Filed With SEC on November 24, 2021)

License Agreement, dated as of November 24, 2021, by and between Seelos Therapeutics, Inc. and iX Biopharma Europe Limited (Filed With SEC on November 24, 2021)

Common Stock Purchase Agreement, dated as of November 24, 2021, by and between Seelos Therapeutics, Inc. and iX Biopharma Europe Limited (Filed With SEC on November 24, 2021)

Acknowledgment and Termination Agreement, dated as of June 14, 2021, by and between Seelos Therapeutics, Inc. and Lind Global Asset Management II, LLC (Filed With SEC on June 17, 2021)

Underwriting Agreement, dated as of May 20, 2021, by and between Seelos Therapeutics, Inc. and Guggenheim Securities, LLC (Filed With SEC on May 21, 2021)

Non-Employee Director Compensation Policy (Filed With SEC on April 30, 2021)

Amendment No. 4 to Asset Purchase Agreement, dated February 15, 2021, by and between Seelos Corporation and Phoenixus AG (Filed With SEC on February 18, 2021)

Underwriting Agreement, dated as of January 25, 2021, by and between Seelos Therapeutics, Inc. and BTIG, LLC (Filed With SEC on January 26, 2021)

Form of Convertible Promissory Note due December 11, 2022 (Filed With SEC on December 17, 2020)

Securities Purchase Agreement, dated as of December 11, 2020, by and between Seelos Therapeutics, Inc. and Lind Global Asset Management II, LLC (Filed With SEC on December 17, 2020)

Security Agreement, dated as of December 11, 2020, by and between Seelos Therapeutics, Inc. and Lind Global Asset Management II, LLC (Filed With SEC on December 17, 2020)

Form of Warrant (Filed With SEC on September 9, 2020)

Securities Purchase Agreement, dated September 4, 2020 (Filed With SEC on September 9, 2020)

Placement Agency Agreement, dated September 4, 2020 (Filed With SEC on September 9, 2020)

Description of Securities of Seelos Therapeutics, Inc (Filed With SEC on March 17, 2020)

Amendment to License Agreement, dated as of February 8, 2019, by and among Ligand Pharmaceuticals Incorporated, Neurogen Corporation, CyDex Pharmaceuticals, Inc., and Seelos... (Filed With SEC on March 17, 2020)

Underwriting Agreement, dated as of March 11, 2020, by and between Seelos Therapeutics, Inc. and The Benchmark Company, LLC, as representative of the underwriters named therein (Filed With SEC on March 12, 2020)

Underwriting Agreement, dated as of February 10, 2020, by and between Seelos Therapeutics, Inc. and The Benchmark Company, LLC, as representative of the underwriters named therein (Filed With SEC on February 11, 2020)

Form of Underwriting Agreement (Filed With SEC on January 30, 2020)

Stock Purchase Agreement, dated as of January 2, 2020, by and between Seelos Therapeutics, Inc. and Phoenixus AG (Filed With SEC on January 3, 2020)

Amendment No. 2 to Asset Purchase Agreement, dated as of December 31, 2018, by and between Seelos Therapeutics, Inc. and Phoenixus AG f/k/a Vyera Pharmaceuticals AG and Turing... (Filed With SEC on November 7, 2019)

Amended and Restated Exclusive License Agreement, dated August 29, 2019, by and between Seelos Therapeutics, Inc. and Stuart Weg, MD (Filed With SEC on November 7, 2019)

Amendment No. 3 to Asset Purchase Agreement, dated October 15, 2019, by and between Seelos Therapeutics, Inc. and Phoenixus AG (Filed With SEC on October 21, 2019)

Form of Warrant (Filed With SEC on August 27, 2019)

Form of Securities Purchase Agreement, dated August 23, 2019 (Filed With SEC on August 27, 2019)

Placement Agency Agreement, dated August 23, 2019 (Filed With SEC on August 27, 2019)

Form of Leak-Out Agreement (Filed With SEC on August 27, 2019)

Seelos Therapeutics, Inc. 2019 Inducement Plan (Filed With SEC on August 14, 2019)

Equity Distribution Agreement, dated as of June 17, 2019, by and between Seelos Therapeutics, Inc. and Piper Jaffray & Co (Filed With SEC on June 18, 2019)

Non-Employee Director Compensation Policy (Filed With SEC on March 26, 2019)

Employment Agreement by and between Seelos Therapeutics, Inc. and Raj Mehra, Ph.D., dated as of March 20, 2019 (Filed With SEC on March 26, 2019)

Form of Fourth Amendment Agreement (Filed With SEC on March 8, 2019)

Asset Purchase Agreement, dated February 15, 2019, by and between Seelos Therapeutics, Inc. and Bioblast Pharma Ltd (Filed With SEC on February 19, 2019)

Form of Series A Warrant, issued to investors on January 31, 2019 (Filed With SEC on February 6, 2019)

Form of Series B Warrant, issued to investors on January 31, 2019 (Filed With SEC on February 6, 2019)

Amendment No. 3 to Agreement and Plan of Merger, dated January 16, 2019, by and among Apricus Biosciences, Inc., Arch Merger Sub, Inc. and Seelos Therapeutics, Inc (Filed With SEC on January 16, 2019)

Form of Third Amendment Agreement (Filed With SEC on January 16, 2019)

Form of Second Amendment Agreement (Filed With SEC on January 4, 2019)

Amendment No. 2 to Agreement and Plan of Merger, dated December 14, 2018, by and among Apricus Biosciences, Inc., Arch Merger Sub, Inc. and Seelos Therapeutics, Inc (Filed With SEC on December 14, 2018)

Form of Investor Warrants (Filed With SEC on November 16, 2018)

Form of Amendment Agreement (Filed With SEC on November 16, 2018)

Amendment No. 1 to Agreement and Plan of Merger, dated October 16, 2018, by and among Apricus Biosciences, Inc., Arch Merger Sub, Inc. and Seelos Therapeutics, Inc (Filed With SEC on October 17, 2018)

Form of Investor Warrants (Filed With SEC on October 17, 2018)

Registration Rights Agreement, dated as of October 16, 2018, by and among Apricus Biosciences, Inc. and certain investors named therein (Filed With SEC on October 17, 2018)

Securities Purchase Agreement, dated as of October 16, 2018, by and among Apricus Biosciences, Inc., Seelos and certain investors named therein (Filed With SEC on October 17, 2018)

Form of Escrow Agreement (Filed With SEC on October 17, 2018)

Form of Lock-Up Agreement (Filed With SEC on October 17, 2018)

Form of Voting Agreement (Filed With SEC on September 21, 2018)

Form of Warrant (Filed With SEC on September 21, 2018)

Form of Wainwright Warrant (Filed With SEC on September 21, 2018)

Form of Registration Rights Agreement (Filed With SEC on September 21, 2018)

Securities Purchase Agreement dated as of September 20, 2018, between Apricus Biosciences, Inc. and the purchaser named in the signature pages thereto (Filed With SEC on September 21, 2018)

Second Amended and Restated Employment Agreement, by and between the Company and Richard Pascoe, dated August 30, 2018 (Filed With SEC on August 31, 2018)

Release of Claims by and between the Company and Brian Dorsey, dated August 30, 2018 (Filed With SEC on August 31, 2018)

Form of Option Agreement under the Seelos Therapeutics, Inc. 2016 Equity Incentive Plan (Filed With SEC on August 31, 2018)

Engagement Letter, between Apricus Biosciences, Inc. and Canaccord Genuity LLC, dated as of March 22, 2018 (Filed With SEC on August 31, 2018)

Form of Indemnification Agreement for Apricus Biosciences, Inc. Directors and Officers (Filed With SEC on August 31, 2018)

License Agreement, dated September 21, 2016, by and among Seelos Therapeutics, Inc., Ligand Pharmaceuticals Incorporated, Neurogen Corporation and CyDex Pharmaceuticals (Filed With SEC on August 31, 2018)

Asset Purchase Agreement, dated as of March 6, 2018, by and between Seelos Therapeutics, Inc. and Vyera Pharmaceuticals AG f/k/a Turing Pharmaceuticals AG (Filed With SEC on August 31, 2018)

Amendment to Asset Purchase Agreement, dated as of May 18, 2018, by and between Seelos Therapeutics, Inc. and Vyera Pharmaceuticals AG f/k/a Turing Pharmaceuticals AG (Filed With SEC on August 31, 2018)

Indemnity Agreement, dated July 8, 2016, by and between Seelos Therapeutics, Inc. and Raj Mehra, Ph.D (Filed With SEC on August 31, 2018)

Form of Seelos Therapeutics, Inc. Note Purchase Agreement (Filed With SEC on August 31, 2018)

Form of Seelos Therapeutics, Inc. Convertible Promissory Note (Filed With SEC on August 31, 2018)

Seelos Therapeutics, Inc. 2016 Equity Incentive Plan (Filed With SEC on August 31, 2018)

Agreement and Plan of Merger, dated July 30, 2018, by and among Apricus Biosciences, Inc., Arch Merger Sub, Inc. and Seelos Therapeutics, Inc (Filed With SEC on July 30, 2018)

Form of Support Agreement, by and between Apricus Biosciences, Inc., Seelos Therapeutics, Inc. and certain stockholders of Apricus Biosciences, Inc (Filed With SEC on July 30, 2018)

Support Agreement, dated July 30, 2018, by and between Apricus Biosciences, Inc., Seelos Therapeutics, Inc. and Raj Mehra (Filed With SEC on July 30, 2018)

Form of CVR Agreement (Filed With SEC on July 30, 2018)

Amendment to Warrant to Purchase Common Stock, dated as of June 22, 2018, by and between the Company and Sarissa Offshore (Filed With SEC on June 22, 2018)

Amendment No. 1 to Subscription Agreement, dated as of June 22, 2018, by and between the Investors and the Company (Filed With SEC on June 22, 2018)

Amendment to Warrant to Purchase Common Stock, dated as of March 27, 2018 (Filed With SEC on March 29, 2018)

Form of Warrant (Filed With SEC on March 29, 2018)

Form of Placement Agent Warrant (Filed With SEC on March 29, 2018)

Form of Securities Purchase Agreement (Filed With SEC on March 29, 2018)

Engagement Agreement, dated as of March 27, 2018, between the Company and H.C. Wainwright & Co., LLC (Filed With SEC on March 29, 2018)

Non-Employee Director Compensation Policy, effective January 3, 2017 (Filed With SEC on March 1, 2018)

Form of Warrant (Filed With SEC on September 11, 2017)

Form of Registration Rights Agreement (Filed With SEC on September 11, 2017)

Securities Purchase Agreement dated as of September 10, 2017, between Apricus Biosciences, Inc. and each purchaser named in the signature pages thereto (Filed With SEC on September 11, 2017)

Engagement Letter between Apricus Biosciences, Inc. and H.C. Wainwright & Co., LLC, dated as of September 10, 2017 (Filed With SEC on September 11, 2017)

APRICUS BIOSCIENCES, INC. AMENDMENT TO SECURITIES PURCHASE AGREEMENT AND WARRANT TO PURCHASE COMMON STOCK (Filed With SEC on April 21, 2017)

____________ SHARES OF COMMON STOCK AND _____________ WARRANTS OF APRICUS BIOSCIENCES, INC. UNDERWRITING AGREEMENT (Filed With SEC on April 20, 2017)

____________ SHARES OF COMMON STOCK AND _____________ WARRANTS OF APRICUS BIOSCIENCES, INC. UNDERWRITING AGREEMENT (Filed With SEC on April 17, 2017)

COMMON STOCK PURCHASE WARRANT APRICUS BIOSCIENCES, INC. (Filed With SEC on April 17, 2017)

APRICUS BIOSCIENCES, INC. AMENDED AND RESTATED EMPLOYMENT AGREEMENT (Filed With SEC on March 13, 2017)

APRICUS BIOSCIENCES, INC. SECOND AMENDED AND RESTATED EMPLOYMENT AGREEMENT (Filed With SEC on March 13, 2017)

ASSET PURCHASE AGREEMENT By and between FERRING INTERNATIONAL CENTER S.A. And APRICUS BIOSCIENCES, INC., NEXMED (U.S.A.), INC., NEXMED HOLDINGS, INC., AND NEXMED INTERNATIONAL... (Filed With SEC on March 8, 2017)

LICENSE AGREEMENT (Filed With SEC on March 8, 2017)

TRANSITION SERVICES AGREEMENT (Filed With SEC on March 8, 2017)

COMMON STOCK PURCHASE WARRANT APRICUS BIOSCIENCES, INC. (Filed With SEC on September 28, 2016)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on September 28, 2016)

COMMON STOCK PURCHASE WARRANT APRICUS BIOSCIENCES, INC. (Filed With SEC on September 26, 2016)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on September 26, 2016)

430 Park Avenue | New York, New York 10022 | 212 ###-###-#### Security services provided by H.C. Wainwright & Co., LLC | Member: FINRA/SIPC (Filed With SEC on September 26, 2016)

COMMON STOCK PURCHASE AGREEMENT (Filed With SEC on July 6, 2016)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on July 6, 2016)

EMPLOYMENT TRANSITION AGREEMENT (Filed With SEC on May 9, 2016)

APRICUS BIOSCIENCES, INC. AMENDED AND RESTATED EMPLOYMENT AGREEMENT (Filed With SEC on May 9, 2016)

APRICUS BIOSCIENCES, INC. 2012 STOCK LONG TERM INCENTIVE PLAN RESTRICTED STOCK UNIT AWARD GRANT NOTICE AND RESTRICTED STOCK UNIT AWARD AGREEMENT (Filed With SEC on May 9, 2016)

APRICUS BIOSCIENCES, INC. NON-EMPLOYEE DIRECTOR COMPENSATION POLICY (EFFECTIVE APRIL 5, 2016) (Filed With SEC on May 9, 2016)

APRICUS BIOSCIENCES, INC. WARRANT TO PURCHASE COMMON STOCK (Filed With SEC on January 13, 2016)

AMENDMENT TO WARRANTS (Filed With SEC on January 13, 2016)

[To be separately provided to the Investors] (Filed With SEC on January 13, 2016)

[To be separately provided to the Investor] (Filed With SEC on January 13, 2016)

LICENSE AGREEMENT AND AMENDMENT by and between WARNER CHILCOTT COMPANY, LLC (SUCCESSOR-IN-INTEREST TO WARNER CHILCOTT COMPANY, INC.) and NEXMED (U.S.A.), INC. Dated as of... (Filed With SEC on November 5, 2015)

SECOND AMENDMENT TO LOAN AND SECURITY AGREEMENT (Filed With SEC on May 11, 2015)

APRICUS BIOSCIENCES, INC. EMPLOYMENT AGREEMENT (Filed With SEC on March 16, 2015)

APRICUS BIOSCIENCES, INC. WARRANT TO PURCHASE COMMON STOCK (Filed With SEC on February 12, 2015)

[To be separately provided to the Investors] (Filed With SEC on February 12, 2015)

[To be separately provided to the Investor] (Filed With SEC on February 12, 2015)

COMMON STOCK PURCHASE WARRANT APRICUS BIOSCIENCES, INC. (Filed With SEC on October 20, 2014)

WARRANT TO PURCHASESTOCK (Filed With SEC on October 20, 2014)

LICENSE AGREEMENT byand between FORENDO PHARMA LTD. and NEXMED (U.S.A.),INC., a wholly owned subsidiary of APRICUS BIOSCIENCES, INC. October 17, 2014 (Filed With SEC on October 20, 2014)

APRICUS BIOSCIENCES, INC. STOCK ISSUANCE AGREEMENT (Filed With SEC on October 20, 2014)

LOAN AND SECURITY AGREEMENT (Filed With SEC on October 20, 2014)

COMMON STOCK PURCHASE AGREEMENT (Filed With SEC on August 12, 2014)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on August 12, 2014)

AMENDMENT TO STOCK PURCHASE AGREEMENT (Filed With SEC on August 11, 2014)

APRICUS BIOSCIENCES, INC. 2012 STOCK LONG TERM INCENTIVE PLAN STOCK OPTION GRANT NOTICE AND STOCK OPTION AGREEMENT (Filed With SEC on August 11, 2014)

APRICUS BIOSCIENCES, INC. NON-EMPLOYEE DIRECTOR COMPENSATION POLICY (AS ADOPTED AUGUST 8, 2014) (Filed With SEC on August 11, 2014)

6,000,000 Shares of Common Stock, par value$0.001 Warrants to Purchase 3,000,000 Shares of Common Stock and 900,000 Over-Allotment Shares Over-Allotment Warrants to Purchase... (Filed With SEC on May 24, 2013)

WARRANT TO PURCHASE COMMON STOCK (Filed With SEC on May 24, 2013)

Amendment and Termination of Shareholder Rights Agreement (Filed With SEC on May 16, 2013)

APRICUS BIOSCIENCES, INC. CONTROLLED EQUITY OFFERING AMENDMENT NO. 1 TO CONTROLLED EQUITY OFFERING AGREEMENT (Filed With SEC on May 10, 2013)

ASSETPURCHASE AGREEMENT (Filed With SEC on April 1, 2013)

APRICUS BIOSCIENCES, INC. EMPLOYMENT AGREEMENT (Filed With SEC on March 20, 2013)

APRICUS BIOSCIENCES, INC. AMENDED AND RESTATED EMPLOYMENTAGREEMENT (Filed With SEC on March 20, 2013)

APRICUS BIOSCIENCES, INC. EMPLOYMENT AGREEMENT (Filed With SEC on March 20, 2013)

AMENDMENT (Filed With SEC on March 18, 2013)

AMENDED AND RESTATED 7% CONVERTIBLE NOTE DUE DECEMBER 31, 2014 OF APRICUS BIOSCIENCES, INC. (Filed With SEC on March 18, 2013)

REAL ESTATE PURCHASE AGREEMENT (Filed With SEC on March 18, 2013)

AGREEMENT (Filed With SEC on March 18, 2013)

SEPARATION AGREEMENT AND MUTUAL RELEASE (Filed With SEC on March 18, 2013)

STOCK CONTRIBUTIONAGREEMENT (Filed With SEC on July 13, 2012)

REGISTRATIONRIGHTS AND TRANSFER RESTRICTION AGREEMENT (Filed With SEC on July 13, 2012)

STOCK PURCHASE AGREEMENT (Filed With SEC on March 13, 2012)

CONSULTING AGREEMENT (Filed With SEC on March 13, 2012)

4,938,272 Shares of Common Stock, par value $0.001 Warrants to Purchase 2,469,136 Shares of Common Stock and 740,740 Over-Allotment Shares Over-Allotment Warrants to Purchase... (Filed With SEC on February 13, 2012)

APRICUS BIOSCIENCES, INC. WARRANT TO PURCHASE COMMON STOCK (Filed With SEC on February 13, 2012)

CONTROLLED EQUITY OFFERING AGREEMENT (Filed With SEC on December 30, 2011)

AMENDED AND RESTATED EMPLOYMENT AGREEMENT (Filed With SEC on November 14, 2011)

EMPLOYMENT AGREEMENT (Filed With SEC on August 15, 2011)

STOCK PURCHASE AGREEMENT (Filed With SEC on July 6, 2011)

SEPARATION AGREEMENT (Filed With SEC on June 2, 2011)

EMPLOYMENT AGREEMENT (Filed With SEC on June 2, 2011)

Custodian (Filed With SEC on March 24, 2011)

FIRST AMENDMENT TO THE EMPLOYMENT AGREEMENT (Filed With SEC on March 10, 2011)

AMENDED AND RESTATED EMPLOYMENT AGREEMENT (Filed With SEC on March 10, 2011)

FIRST AMENDMENT TO THE AMENDED AND RESTATED EMPLOYMENT AGREEMENT (Filed With SEC on March 10, 2011)

AMENDMENTNO. 2 TO RIGHTS AGREEMENT (Filed With SEC on December 10, 2009)

AGREEMENTAND PLAN OF MERGER BY ANDAMONG NEXMED,INC., BQACQUISITION CORP., BIO-QUANT,INC., ALI SAMERAL-ASSAAD, as SHAREHOLDERREPRESENTATIVE and as toSections 4.1(c) and Article... (Filed With SEC on November 23, 2009)

TerminationAgreement (Filed With SEC on August 10, 2009)

FIRSTAMENDMENT TO ASSETPURCHASE AGREEMENT (Filed With SEC on April 17, 2009)

ASSETPURCHASE AGREEMENT dated asof February3, 2009 between WARNERCHILCOTT COMPANY INC., and NEXMEDINC. TABLEOF CONTENTS (Filed With SEC on February 5, 2009)

LICENSEAGREEMENT (Filed With SEC on February 5, 2009)

PURCHASE AGREEMENT (Filed With SEC on July 3, 2008)

7% CONVERTIBLE NOTE DUE DECEMBER 31, 2011 OF NEXMED, INC. Note No.: ___ Original Principal Amount: ________ Issuance Date: June 27, 2008 New York, New York (Filed With SEC on July 3, 2008)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on July 3, 2008)

NEXMED (U.S.A.), INC., AS MORTGAGOR and THE TAIL WIND FUND LTD. AND SOLOMON STRATEGIC HOLDINGS, INC., COLLECTIVELY AS MORTGAGEE MORTGAGE, SECURITY AGREEMENT AND ASSIGNMENT OF... (Filed With SEC on July 3, 2008)

SUBSIDIARY GUARANTY (Filed With SEC on July 3, 2008)

/s/ Vivian Liu /s/ Hemanshu Pandya Name: Vivian Liu Name: Hemanshu Pandya Title: President and Chief Executive Officer Title: Vice President and ChiefOperating Officer (Filed With SEC on July 1, 2008)

EMPLOYMENT AGREEMENT (Filed With SEC on May 30, 2008)

Binding Commitment for $3 million Credit Line for NexMed, Inc. (NASDAQ: NEXM) (Filed With SEC on May 14, 2008)

LICENSE AGREEMENT (Filed With SEC on March 12, 2008)

EMPLOYMENT AGREEMENT (Filed With SEC on November 5, 2007)

NEXMED, INC. COMMON STOCK PURCHASE WARRANT (Filed With SEC on October 31, 2007)

PURCHASE AGREEMENT (Filed With SEC on October 31, 2007)

NEXMED, INC. 8.0% Senior Secured Note Due June 30, 2009 (Filed With SEC on October 31, 2007)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on October 31, 2007)

AGREEMENT OF SALE NexMed (USA), Inc., Seller and Pharmar & Pharmar LLC, Buyer (Filed With SEC on August 14, 2007)

AMENDMENT NO. 1 TO RIGHTS AGREEMENT (Filed With SEC on January 22, 2007)

COMMON STOCK PURCHASE WARRANT Warrant To Purchase 2,663,400 Shares of Common Stock of NEXMED, INC. (Filed With SEC on December 21, 2006)

COMMON STOCK AND WARRANT PURCHASE AGREEMENT by and among NexMed, Inc., as Issuer and Seller and the Purchasers named herein, as Purchasers December 20, 2006 Table of Exhibits and... (Filed With SEC on December 21, 2006)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on December 21, 2006)

NEXMED, INC. COMMON STOCK PURCHASE WARRANT (Filed With SEC on December 4, 2006)

SECURITIES PURCHASE AGREEMENT by and between NEXMED, INC., NEXMED (U.S.A.), INC. and METRONOME LPC 1, INC., dated as of November 30, 2006 SECURITIES PURCHASE AGREEMENT (Filed With SEC on December 4, 2006)

NEXMED, INC. 7.5% Senior Secured Note Due December 31, 2007 (Filed With SEC on December 4, 2006)

EMPLOYMENT AGREEMENT (Filed With SEC on March 16, 2006)

COMMON STOCK PURCHASE WARRANT Warrant To Purchase _________ Shares of Common Stock of NEXMED, INC. (Filed With SEC on January 27, 2006)

COMMON STOCK AND WARRANT PURCHASE AGREEMENT by and among NexMed, Inc., as Issuer and Seller and the Purchasers named herein, as Purchasers January 23, 2006 Table of Exhibits and... (Filed With SEC on January 27, 2006)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on January 27, 2006)

Category

Industry

Companies

Contracts

APRICUS BIOSCIENCES, INC. Contracts & Agreements